Search | IOVS | ARVO Journals

Showing 1 – 20 of 73

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Cholesterol Crystals Drive Pathogenesis of Diabetic Retinopathy

Md Sohel; Amina Jamil; Tim F. Dorweiler; Xue Cai; Nicole EL-Darzi; Rui Cheng; Jian-Xing (Jay) Ma; Irina Pikuleva; George Abela; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4835.

ARVO Annual Meeting Abstract June 2025

Intravitreal administration of AAV8 ELOVL2/ELOVL4 combination as a novel therapeutic approach for Retinopathy of Prematurity

Fadeela Sheini; Sergio Li Calzi; Dorota Skowronska-Krawczyk; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2571.

ARVO Annual Meeting Abstract June 2024

Systemic anti-ceramide immunotherapy corrects diabetic retinopathy by restoring hematopoietic stem cell function

Tim Florian Dorweiler; Arjun Singh; Sandra O'Reilly; Gary Blanchard; Maria B Grant; Richard Kolesnick; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3836.

ARVO Annual Meeting Abstract June 2023

Inhibition of ceramide rich platforms by anti-ceramide immunotherapy prevents retinal endothelial cell damage and the development of diabetic retinopathy.

Tim F. Dorweiler; Arjun Singh; Richard N Kolesnick; Julia V. Busik

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):941.

ARVO Annual Meeting Abstract June 2023

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Ram Prasad; Jason Floyd; Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Sergio Li Calzi; Dibyendu Chakraborty; Angela Harbour; Aayush Rohella; Irina A Pikuleva; Julia V. Busik; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):938.

ARVO Annual Meeting Abstract June 2023

Extracellular Vesicles in Diabetic Retinopathy

Julia V. Busik

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1944.

ARVO Annual Meeting Abstract June 2023

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Cristiano Vieira; Ram Prasad; Sergio Li Calzi; Irina A Pikuleva; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1834.

ARVO Annual Meeting Abstract June 2023

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Sergio Li Calzi; Bright Asare-Bediako; Yvonne Adu-Agyeiwaah; Ram Prasad; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3866.

Retina April 2023

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

PDF

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sergio Li Calzi; Mariana DuPont; Jason Floyd; Sanford Boye; Vince Chiodo; Julia V. Busik; Maria B. Grant
TAGS: diabetes mellitus, diabetes mellitus, type 2, diabetic retinopathy, intravitreal injections, mice, retina, blood capillaries, inflammation, hypoxia
Trans. Vis. Sci. Tech.. 2023; 12(4):20. https://doi.org/10.1167/tvst.12.4.20

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

Anti-ceramide immunotherapy for diabetic retinopathy

Tim Florian Dorweiler; Peter Nolan; Richard N. Kolesnick; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):459.

ARVO Annual Meeting Abstract June 2022

Correction of diabetic retinopathy by mitochondrial transfer

Denis A Proshlyakov; Sandra S Hammer; Sergio Li Calzi; Tim Florian Dorweiler; Cristiano P. Vieira; Kiera Fisher; Shari Atilano; M.Cristina Kenney; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):791 – F0350.

ARVO Annual Meeting Abstract June 2022

Intermittent fasting prevents cholesterol accumulation, cholesterol crystal formation and the development of diabetic retinopathy.

Sandra S Hammer; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):782 – F0341.

ARVO Annual Meeting Abstract June 2022

Intravitreal administration of AAV2-SIRT1 reverses diabetic retinopathy (DR) in a murine model of type 2 diabetes (T2D)

Maria B Grant; Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2310.

ARVO Annual Meeting Abstract June 2022

Oral administration of alpha-cyclodextrin reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Sandra S Hammer; Cristiano P. Vieira; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Ram Prasad; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3591 – A0046.

ARVO Annual Meeting Abstract June 2021

Statins and α cyclodextrin treatments prevent cholesterol crystal-induced pathology in human retinal endothelial cells and in db/db mice.

Sandra S Hammer; Delaney McFarland; George Abela; Sergio Li Calzi; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2928.

ARVO Annual Meeting Abstract June 2021

Intravitreal AAV2-SIRT1 administration reverses diabetic retinopathy in db/db mice

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sandra S Hammer; Sergio Li Calzi; Julia V Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1106.

ARVO Annual Meeting Abstract July 2019

Modulation of Sphingolipid metabolites in Type 2 Diabetic Retinopathy

Koushik Mondal; Todd Lydic; Rajashekhar Gangaraju; Julia V Busik; Nawajes A Mandal

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2681.

ARVO Annual Meeting Abstract July 2019

EFFECT OF SERUM STARVATION ON THE SIRT1-LXR SIGNALING PATHWAY IN RETINAL ENDOTHELIAL CELLS

Maximilian Sandler; Sandra S Hammer; Delaney Marie McFarland; Elahe Crockett-Torabi; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2702.

ARVO Annual Meeting Abstract July 2019

Control of retinal cholesterol levels by fasting-induced activation of SIRT1-LXR pathway in diabetic retinopathy.

Delaney McFarland; Sandra S Hammer; Maria B Grant; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2704.

ARVO Annual Meeting Abstract July 2019

SPHINGOLIPID METABOLISM CONTRIBUTES TO MITOCHONDRIAL DYSFUNCTON INDUCED BY DIABETOGENIC CONDITION IN RETINAL EPITHELIAL CELLS

Kiera Fisher; Yan Levitsky; Sandra S Hammer; Todd Lydic; David Pegouske; Denis Proshlyakov; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2706.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Cholesterol Crystals Drive Pathogenesis of Diabetic Retinopathy

Intravitreal administration of AAV8 ELOVL2/ELOVL4 combination as a novel therapeutic approach for Retinopathy of Prematurity

Systemic anti-ceramide immunotherapy corrects diabetic retinopathy by restoring hematopoietic stem cell function

Inhibition of ceramide rich platforms by anti-ceramide immunotherapy prevents retinal endothelial cell damage and the development of diabetic retinopathy.

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Extracellular Vesicles in Diabetic Retinopathy

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

Anti-ceramide immunotherapy for diabetic retinopathy

Correction of diabetic retinopathy by mitochondrial transfer

Intermittent fasting prevents cholesterol accumulation, cholesterol crystal formation and the development of diabetic retinopathy.

Intravitreal administration of AAV2-SIRT1 reverses diabetic retinopathy (DR) in a murine model of type 2 diabetes (T2D)

Oral administration of alpha-cyclodextrin reverses diabetic retinopathy in db/db mice

Statins and α cyclodextrin treatments prevent cholesterol crystal-induced pathology in human retinal endothelial cells and in db/db mice.

Intravitreal AAV2-SIRT1 administration reverses diabetic retinopathy in db/db mice

Modulation of Sphingolipid metabolites in Type 2 Diabetic Retinopathy

EFFECT OF SERUM STARVATION ON THE SIRT1-LXR SIGNALING PATHWAY IN RETINAL ENDOTHELIAL CELLS

Control of retinal cholesterol levels by fasting-induced activation of SIRT1-LXR pathway in diabetic retinopathy.

SPHINGOLIPID METABOLISM CONTRIBUTES TO MITOCHONDRIAL DYSFUNCTON INDUCED BY DIABETOGENIC CONDITION IN RETINAL EPITHELIAL CELLS

To View More...

You must be signed into an individual account to use this feature.